What is Late-Line RRMM and How is it Determined?

Author(s):

Panelists discuss how the term "late-line" in relapsed/refractory multiple myeloma typically refers to patients who have progressed through multiple previous treatment regimens, indicating a more advanced disease state that has become resistant to several standard therapeutic approaches.

Now Viewing

EP: 1.What is Late-Line RRMM and How is it Determined?

EP: 2.Challenges in Managing Late-Line RRMM

EP: 3.Linda’s Treatment History and Challenges in Coping With Multiple Relapses

EP: 4.Current Treatment Landscape for Late-Line RRMM

EP: 5.Clinical Factors Evaluated When Choosing Treatment in Late-Line RRMM

EP: 6.Patient’s Experience in Shared Decision Making in RRMM

EP: 7.Practical Considerations for Therapies Considered by the Patient and Caregivers in RRMM

EP: 8.Managing Treatment Logistics: Navigating Travel, Lodging and Caregiver Support

EP: 9.Recent Updates in Bispecifics and Their Use in Clinical Practice

EP: 10.Recent Updates in CAR-T Cell Therapy and Their Impact in Clinical Practice in RRMM

EP: 11.Balancing Benefits and Risks: Patients’ Experiences With Newer Therapies and Side Effects in Late-Line RRMM

EP: 12.Balancing Efficacy and Quality of Life in Late-Line RRMM

EP: 13.Aligning Treatment Goals: Key Considerations for Patients and Caregivers in Late-Line RRMM

EP: 14.Lifestyle Modifications That Have Been Helpful in RRMM

EP: 15.Addressing the Most Common Concerns Patients and Caregivers Have in Late-Line RRMM

EP: 16.Effective Communication Strategies: Sharing Concerns With Your Medical Team in Late-Line RRMM

EP: 17.Guidance for Caregivers: Supporting a Loved One Through Late-Line RRMM

EP: 18.Navigating RRMM: Helpful Resources and Advice for Patients Facing Disease Progression

Video content above is prompted by the following:

What does "late-line" relapsed/refractory multiple myeloma mean, and how is it determined that a patient is “late-line”?

Stay up to date on cancer updates, research and education

Subscribe Now!